New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 20, 2013
04:55 EDTBWA, BWA, AVY, AVY, CMI, CMI, DHR, DHR, UNP, UNP, HON, HON, MTZ, MTZ, SPR, SPR, WSO, WSOBarclays to host a conference
Industrial Select Conference is being held in Miami on February 20-21.
News For BWA;AVY;CMI;DHR;UNP;HON;MTZ;SPR;WSO From The Last 14 Days
Check below for free stories on BWA;AVY;CMI;DHR;UNP;HON;MTZ;SPR;WSO the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
September 16, 2014
08:01 EDTBWABorgWarner produced 1.5M exhaust gas recirculation valves in China
BorgWarner's production facility in Ningbo, China, has produced more than 1.5M exhaust gas recirculation valves for passenger cars and commercial diesel vehicles. Starting in 2010 with the production of EGR valves and adding EGR coolers and EGR modules in 2013, BorgWarner's plant in Ningbo has been supplying several European and Chinese customers. BorgWarner expects demand to increase over the coming years and plans to produce one million EGR valves annually in Ningbo beginning in 2016.
05:32 EDTCMICummins downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo downgraded Cummins to Market Perform on concerns the company will struggle to meet 2015 consensus expectations due to emerging market demand weakness, slower power generation improvement and warranty accrual headwinds in Engines. Wells lowered its price target range for shares to $145-$148 from $170-$173.
September 15, 2014
11:48 EDTHONHoneywell sees 2015 pension as 'a little bit of a headwind'
Subscribe for More Information
11:32 EDTHONHoneywell says would do a larger acquisition if "it makes sense"
Targeting $10B+ in strategic M&A over next five years.
11:15 EDTHONHoneywell sees 2018 sales $46B-$51B
Says aerospace continues to "churn along," says revenues in line with aftermarkets. Says UOP "doing very well." Says continues to be strong in China, Middle East, India. Sees dividends growing faster than net income growth. Believes company will do well in terms of organic growth, will be good stewards of cash. Comments made by CFO Tom Szlosek at the Morgan Stanley Laguna Conference.
10:51 EDTHONHoneywell sees FY14 EPS $5.45-$5.55, consensus $5.54
Subscribe for More Information
10:47 EDTHONHoneywell sees Q4 EPS $1.42-$1.47, consensus $1.47
Subscribe for More Information
10:46 EDTHONHoneywell sees Q3 EPS $1.37-$1.42, consensus $1.42
Sees Q3 sales $9.9B-$10.1B, consensus $10.06B. Sees Q3 segment margin ~17.2%. Comments from slides that will be presented at the Morgan Stanley Laguna Conference.
08:56 EDTDHRDanaher: It's important not to read too much into 2 deals for company direction
Subscribe for More Information
08:49 EDTDHRDanaher expects global dentistry market to grow 3%-5%
Subscribe for More Information
08:47 EDTDHRDanaher expects Nobel Biocare acquisition to be accretive to EPS by 5c in 2015
Subscribe for More Information
07:42 EDTHON, WSO, DHRMorgan Stanley to hold a conference
Subscribe for More Information
05:58 EDTDHRDanaher to host conference call
Subscribe for More Information
05:20 EDTDHRDanaher to acquire Nobel Biocare Holding for CHF 17.10 per share
Danaher has entered into a definitive transaction agreement with Nobel Biocare Holding AG pursuant to which Danaher or one of its direct or indirect subsidiaries will commence a tender offer for all publicly held registered shares of Nobel Biocare in an all-cash transaction valued at approximately $2.2B. The deal is expected to widen Danaher's market presence in the global dental industry and allow Nobel Biocare to accelerate its strategic objectives and future growth. Under the terms of the transaction agreement, Danaher will commence a voluntary all-cash public tender offer of CHF 17.10 per Nobel Biocare share to purchase all of Nobel Biocare's publicly held registered shares. The pre-announcement of the public tender offer is published today. The offer prospectus is expected to be published on or around October 1 and the offer period during which Nobel Biocare shareholders may tender their registered shares is expected to start on or around October 16. In 2013, Nobel Biocare generated annual revenues of approximately $750M. Nobel Biocare would become part of Danaher's $2.2B Dental segment and complements Danaher's position in the implant industry. The Nobel Biocare board has recommended that Nobel Biocare shareholders accept and tender their shares into the offer, which represents a premium of approximately 23% to Nobel Biocare's closing price on July 28, the day before market speculation began regarding a potential sale of the company, or 28% on the basis of the 60 day volume-weighted average price on that date. The offer is expected to be completed in late 2014 or early 2015.
05:17 EDTDHRDanaher to acquire Nobel Biocare Holding for CHF 17.10 per share
Subscribe for More Information
September 9, 2014
11:36 EDTHONHoneywell initiated with a Hold at Societe Generale
Target $100.
07:10 EDTHONGabelli to hold a conference
Subscribe for More Information
September 8, 2014
13:26 EDTBWAFord falls after two notch downgrade at Morgan Stanley
Subscribe for More Information
09:39 EDTSPRSpirit AeroSystems price target raised to $48 from $43 at Sterne Agee
Sterne Agee raised Spirit's price target to $48 from $43 to reflect an increase in margins and lower loss estimates for development programs. Shares are Buy rated.
07:59 EDTBWAMorgan Stanley downgrades Auto sector to Cautious, downgrades Ford
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use